This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Society affairs & governance

EAS President's review of the year

Friday 21 December 2018   (0 Comments)
Share |

Dear friends,

As the year draws to a close, we take time to reflect on the progress we have made in the Society’s activities during 2018.

The Society’s Consensus Panel continue their critical appraisal of the evolving landscape and recent exciting developments in the field, resulting in to two publications in 2018: “Adverse effects of statin therapy: perception vs. the evidence” and “Quantifying Atherogenic Lipoproteins: Current and Future Challenges”.

In Education, we held a very successful Congress in beautiful Lisbon, where more than 2000 delegates came together explore the latest developments in research, and how these may affect clinical diagnosis and treatment. Through collaboration with National Atherosclerosis Societies we funded Travel Grants to investigators from many regions, and held the second meeting with National Society Presidents to further explore how we can collaborate.

With the next generation very much in focus, we have invested in promising early-career scientists by providing Young Investigator Fellowships to attend and present at Congress. We also organised Advanced Courses in Prague, Athens, Debrecen, Copenhagen, Bucharest and Vienna, and Rare Lipid Disorder Courses in Berlin, Lyon, Barcelona and Milan, and supported the European Lipoprotein Club 41st meeting in Tutzing.

Many of the prestigious presentations given at the Congress and Courses are available for EAS members to view on the EAS Academy online educational platform.

The EAS-FH Studies Collaboration (FHSC) achieved major milestones this year, with a successful meeting of the collaborators in Lisbon, the publication of the landmark paper “Overview of the current status of familial hypercholesterolaemia care in over 60 countries”, and, very recently, the number of patient cases in the registry passing the 22,000-mark.

2019 promises to be an exciting year. Among many activities, we are looking forward to: the planned publication of new ESC-EAS guidelines in management of dyslipidaemia; there are several publications from the EAS Consensus Panel in the pipeline, and we will see launch of our new Open Access Journal “Atherosclerosis X”; our Congress in Maastricht EAS 2019 has already received a record number of abstracts, and has a programme filled with the field’s most highly regarded speakers; further Advanced Courses and activities aimed to support young scientists are planned, as is a new update to the “Certificate of Excellence in Lipidology Programme” on the EAS Academy; and the FHSC registry anticipates reaching a total of 40,000 patient records.

Finally, a word of thanks. All EAS activities and initiatives are conceived, planned and carried out by dedicated and driven individuals, who, devote much time, energy and enthusiasm to the life of the Society. So much work is done by so many behind the scenes, in order that EAS can run the publication and educational activities that fulfil our aim - to advance knowledge in the field of atherosclerosis. On behalf of the Executive Committee, I take this opportunity to acknowledge and thank most sincerely every contribution, large or small.

We wish you health and happiness in the holiday season, and scientific success in 2019!

Lale Tokgozoglu MD FACC FESC
President, European Atherosclerosis Society
Professor of Cardiology
Hacettepe University


Membership Software Powered by YourMembership  ::  Legal